What Ever Happened to the Mysterious Nobel Prize Sperm Bank?
By Anna Silman,
The Cut
| 08. 01. 2019
Yesterday, the New York Times published a story about alleged sex trafficker and cartoon villain Jeffrey Epstein’s plan to “seed the human race with his DNA” by impregnating 20 women at once at his New Mexico ranch. According to one scientist, he got his idea from the Repository for Germinal Choice, a sperm bank that was designed to collect the sperm of Nobel Prize winners in order to fill the world with their genius offspring.
Wait — what?
While it sounds like something out of the movie Gattaca, the “Nobel Prize Sperm Bank” really was operational for 20 years, from 1979 to 1999, and based in Escondido, California. It was founded by the multimillionaire optometrist and inventor Robert Graham, an admirer of eugenics who believed the human race was getting progressively dumber and that the only way to stop it was by filling the world with the genetic descendants of Nobel Prize winners. As part of his utopian vision (or dystopian vision, depending on how you look at it), he also planned to recruit only married heterosexual...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...